| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Tata Nifty MidSmall Healthcare Index Fund Reg (G) |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.46 |
| Equity |
100.30 |
| Trep |
0.16 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
41.14% |
| Top 10 Holdings |
61.41% |
| Top 25 Holdings |
93.95% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
61.5 |
| Healthcare |
38.8 |
| Cash |
-0.3 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.87 |
| PE Ratio |
44.47 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Max Healthcare Institute Limited |
16.04 |
| Lupin Limited |
7.93 |
| Fortis Health Care Ltd |
7.00 |
| Aurobindo Pharma Limited |
5.37 |
| Laurus Labs Limited |
4.80 |
| Alkem Laboratories Limited |
4.49 |
| Glenmark Pharmaceuticals Limited |
4.47 |
| Mankind Pharma Limited |
4.43 |
| Biocon Limited |
3.61 |
| IPCA Laboratories Limited |
3.27 |
| Abbott India Limited |
3.15 |
| Krishna Inst of Medical Sciences Ltd. |
2.80 |
| Narayana Hrudalaya Ltd |
2.49 |
| Gland Pharma Limited |
2.47 |
| Glaxosmithkline Pharma Ltd |
2.37 |
| J B Chemicals and Pharma Ltd |
2.30 |
| Aster DM Healthcare Limited |
2.27 |
| Piramal Pharma Limited |
2.13 |
| Cohance Lifesciences Limited |
2.09 |
| Syngene International Limited |
2.05 |
| Ajanta Pharma Limited |
1.83 |
| Dr Lal Path Labs Ltd |
1.77 |
| Neuland Laboratories Limited |
1.74 |
| EQ- GLOBAL HEALTH LTD. |
1.62 |
| Pfizer Limited |
1.46 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
